What is Diasol?
Diasol, Inc. is a specialized manufacturer of hemodialysis concentrates, catering to the varied requirements of patients undergoing dialysis. The company operates with a robust logistical framework, featuring strategically positioned manufacturing facilities in Phoenix, AZ, and Watertown, TN, complemented by extensive distribution warehouses across California and Texas. This infrastructure ensures the efficient and timely delivery of its product line, which includes a range of electrolyte concentrations designed to facilitate optimal dialysis bath prescriptions. Diasol is dedicated to empowering healthcare providers with the essential products needed to deliver superior patient care.
How much funding has Diasol raised?
Diasol has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Diasol
PPP
Public-Private Partnership
What's next for Diasol?
The company's large-scale, late-stage funding context suggests a focus on scaling operations, expanding market reach, and potentially further product development or strategic acquisitions. This substantial capital infusion is likely to fortify Diasol's competitive edge in the hemodialysis concentrate market, enabling it to enhance its manufacturing capabilities and distribution networks. Future growth may involve exploring new therapeutic applications or geographical markets, solidifying its role as a key supplier to healthcare providers.
See full Diasol company page
